I remember some years back when Patrys share price was forced down to .004. Shortly thereafter I sold a largish parcel for 6c. I've long since learned to ignore the daily vicissitudes of stock share prices, especially when they bear no relation to the tangible net asset value of an entity.
Ann: Positive preclinical data for deoxymabs in vasculitis, page-45
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
